Prevention and management of co-morbidities in SLE

Tanmayee Bichile, Michelle Petri

Research output: Contribution to journalShort survey

Abstract

The prognosis and survival of patients with systemic lupus erythematosus (SLE) have improved over the past few decades. The major cause of death is no longer active lupus, but instead cardiovascular disease, complications of renal failure, and malignancy. Co-morbid factors, including both traditional and non-traditional cardiovascular risk factors, can be targeted according to accepted guidelines. We will emphasize the deleterious effect of corticosteroids in contributing to cardiovascular risk and the need to shift maintenance prednisone doses to a much lower threshold.

Original languageEnglish (US)
Pages (from-to)e187-e195
JournalPresse Medicale
Volume43
Issue number6P2
DOIs
StatePublished - Jun 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prevention and management of co-morbidities in SLE'. Together they form a unique fingerprint.

Cite this